ArisGlobal Launches LifeSphere Publishing as Key Component of LifeSphere Regulatory Cloud Platform

Regulatory teams benefit from a streamlined, end-to-end publishing
process

Miami (ots/PRNewswire) - ArisGlobal, a leading provider of life
sciences software that automates core drug development functions for
over 200 life sciences companies, today announced LifeSphere®
Publishing (https://goo.gl/wQ4hBC), a complete, pre-validated
submissions management system that enables life science organizations
to easily plan, compile, publish, and validate regulatory submissions
with full support for all major global eCTD requirements. LifeSphere
Regulatory Publishing can be used as a standalone application or as
an integral part of ArisGlobal's LifeSphere® Regulatory
(https://goo.gl/XBfiMU) end-to-end cloud platform for regulatory
affairs.

As part of the LifeSphere cognitive platform, LifeSphere
Publishing works seamlessly with LifeSphere® EasyDocs
(https://goo.gl/KpDeJX), also announced today, to provide a fully
unified content and submission management solution. Built on open SOA
architecture, the solution offers configurable APIs to enable easy
integration with other document management systems such as
Documentum, D2, SharePoint, and more.

"Many life sciences companies face an increasing volume of digital
assets being created and managed across multiple repositories. This
reality makes it extremely difficult to have true visibility into
where approved content exists across the organization and potentially
leads to compliance issues," said Wim Cypers (https://goo.gl/hBr5m8),
Senior Vice President, Regulatory Affairs of ArisGlobal. "LifeSphere
Publishing and LifeSphere EasyDocs, in combination with LifeSphere
Regulatory, help users to manage, in a single unified platform, all
content related challenges and ensures compliance for years to come."

LifeSphere Publishing offers feature-rich capabilities that
deliver powerful benefits:

- Seamless integration with regulatory information management,
document management, and dossier management systems gives companies
comprehensive capabilities across the product regulatory lifecycle
- An intuitive, easy-to-use and mobile-enabled user interface
enhances the user's experience for compiling, publishing and
validating submissions
- Built-in document management functionalities with lifecycle and
workflow management proactively navigate users through assigned
activities
- eCTD submission lifecycle management and support for FDA
application and submissions ensure compliance
- Pre-validated deployment on the state-of-the-art Amazon Web
Services (AWS) cloud eliminates internal infrastructure and need
for costly upgrades

Learn more: LifeSphere Publishing (https://goo.gl/T4zvvB)

About ArisGlobal

ArisGlobal is a visionary technology company that's transforming
the way today's most successful Life Sciences companies develop
breakthroughs and bring new products to market. Our end-to-end drug
development technology platform, LifeSphere®, integrates our
proprietary Nava® cognitive computing engine to automate all core
functions of the drug development lifecycle. Designed with deep
expertise and a long-term perspective that spans more than 30 years,
LifeSphere® boosts efficiency, ensures compliance, delivers
actionable insights, and lowers total cost of ownership through
multi-tenant Software-as-a-Service (SaaS) architecture. Headquartered
in the United States, ArisGlobal has regional offices in Europe,
India, Japan and China. Visit arisglobal.com (https://goo.gl/fpFnXY),
or follow ArisGlobal on LinkedIn
(https://www.linkedin.com/company/aris-global/) and Twitter
(https://twitter.com/Aris_Global).

Logo: http://mma.prnewswire.com/media/523994/ArisGlobal_Logo.jpg

ots Originaltext: ArisGlobal
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Gregory Belkin
Senior Product Marketing Manager
ArisGlobal
Mobile
+1-978-697-5897
gbelkin@arisglobal.com

Original-Content von: ArisGlobal, übermittelt durch news aktuell